CD79A chimeric antigen receptors
US12060419B2 · kind B2 · utility
0Cited by
38References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 14, 2019 |
| Grant date | Aug 13, 2024 |
| Priority date | — |
| Expiry date | May 9, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/33
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides improved compositions for adoptive cell therapies for cancers that express CD79A.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.